Tuesday 27 June 2006
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust are delighted to publish their Annual Research Report today. The Annual Research Report is a joint publication highlighting important achievements and significant progress in cancer research made by the partnership over the past year. Together, The Institute and the Royal Marsden form Europe’s largest Comprehensive Cancer Centre, with an outstanding national and international reputation.
The report includes in-depth reviews of exciting developments in selected areas of cancer research. Some highlights from this year include research into the causes of childhood leukaemia, advances in the treatment of melanoma and the impact of structural biology in drug development.
Professor Peter Rigby, Chief Executive of The Institute of Cancer Research said: “The Institute and the Royal Marsden work in an exciting and privileged partnership at the very forefront of cancer research. There are few other cancer research organisations in the world where chemists and biologists work side by side with clinicians in the fight against cancer, meaning we truly take research from ‘bench to bedside’. The Annual Research Report showcases some of the great work our teams are undertaking and highlights just how important our partnership is in making suffering from cancer a thing of the past.”
Cally Palmer, Chief Executive for The Royal Marsden NHS Foundation Trust said: “The unique relationship between the Royal Marsden and The Institute enables patients to receive new treatments as quickly as possible. Every day our teams are developing pioneering drugs that will benefit cancer patients in the future. The Annual Research Report highlights the excellent work that our teams have worked on in the past year.”
- ends -
For more information or for a copy of the report please call the Press Offices:
The Institute of Cancer Research
020 7153 5359
The Royal Marsden NHS Foundation Trust
020 7808 2605